Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Al-Sawaf O, Zhang C, Jin HY, Robrecht S, Choi Y, Balasubramanian S, Kotak A, Chang YM, Fink AM, Tausch E, Schneider C, Ritgen M, Kreuzer KA, Chyla B, Paulson JN, Pallasch CP, Frenzel LP, Peifer M, Eichhorst B, Stilgenbauer S, Jiang Y, Hallek M, Fischer K. Al-Sawaf O, et al. Among authors: kotak a. Nat Commun. 2023 Apr 18;14(1):2147. doi: 10.1038/s41467-023-37648-w. Nat Commun. 2023. PMID: 37072421 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 36163885
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Al-Sawaf O, Zhang C, Jin HY, Robrecht S, Choi Y, Balasubramanian S, Kotak A, Chang YM, Fink AM, Tausch E, Schneider C, Ritgen M, Kreuzer KA, Chyla B, Paulson JN, Pallasch CP, Frenzel LP, Peifer M, Eichhorst B, Stilgenbauer S, Jiang Y, Hallek M, Fischer K. Al-Sawaf O, et al. Among authors: kotak a. Nat Commun. 2023 Oct 23;14(1):6724. doi: 10.1038/s41467-023-42562-2. Nat Commun. 2023. PMID: 37872229 Free PMC article. No abstract available.
Growth hormone augmentation in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials.
Mohamed I, Gautam M, Abosheaishaa H, Hussain S, Kumar K, Kotak A, Baugh M, Qureshi R, Jaber F, Dahiya DS, Alba L, Duong N. Mohamed I, et al. Among authors: kotak a. Eur J Gastroenterol Hepatol. 2024 Nov 1;36(11):1259-1266. doi: 10.1097/MEG.0000000000002819. Epub 2024 Jul 8. Eur J Gastroenterol Hepatol. 2024. PMID: 38973533
A curious case of COVID-19: A novel cause of psychosis.
Kaur M, Farooq B, Nagarajah A, Kotak A. Kaur M, et al. Among authors: kotak a. Australas Psychiatry. 2022 Jun;30(3):410-411. doi: 10.1177/10398562221079278. Epub 2022 Mar 25. Australas Psychiatry. 2022. PMID: 35332796 Free PMC article. No abstract available.
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical Trial.
Frishberg Y, Deschênes G, Groothoff JW, Hulton SA, Magen D, Harambat J, Van't Hoff WG, Lorch U, Milliner DS, Lieske JC, Haslett P, Garg PP, Vaishnaw AK, Talamudupula S, Lu J, Habtemariam BA, Erbe DV, McGregor TL, Cochat P; study collaborators. Frishberg Y, et al. Clin J Am Soc Nephrol. 2021 Jul;16(7):1025-1036. doi: 10.2215/CJN.14730920. Epub 2021 May 13. Clin J Am Soc Nephrol. 2021. PMID: 33985991 Free PMC article. Clinical Trial.
SMS SOS: a randomized controlled trial to reduce self-harm and suicide attempts using SMS text messaging.
Stevens GJ, Hammond TE, Brownhill S, Anand M, de la Riva A, Hawkins J, Chapman T, Baldacchino R, Micallef JA, Andepalli J, Kotak A, Gunja N, Page A, Gould G, Ryan CJ, Whyte IM, Carter GL, Jones A. Stevens GJ, et al. Among authors: kotak a. BMC Psychiatry. 2019 Apr 18;19(1):117. doi: 10.1186/s12888-019-2104-9. BMC Psychiatry. 2019. PMID: 30999952 Free PMC article. Clinical Trial.
11 results